DFN-02 Open Label Safety Study in Patients With Acute Migraine
NCT02279082
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
167
Enrollment
INDUSTRY
Sponsor class
Conditions
Acute Migraine
Interventions
DRUG:
DFN-02
Sponsor
Dr. Reddy's Laboratories Limited